Redeye comments on Better Collective ahead of Q1-results (due 21 May after market close) where M&A w...
Redeye leaves a short note following Magle’s announcement yesterday of the initial outcome of the pu...
Q1 EBITDA NOK -6m vs ABGSCe of NOK -1m, Q2 likely weaker New targets more achievable - sales +22% in...
Q1 EBITDA of USD 13.0m, slightly below ABGSCe Small downwards revisions to estimates after Q1 P/NAV ...
25% organic growth, 13% ARR growth y-o-y Slightly higher opex offset by better gross margin Trading ...
Sales 5% vs. ABGSCe, adj. EBITA 7% vs. ABGSCe No material estimate changes Trading at 9-6x EV/EBITA ...
Q1'24 results due 14 May 207% growth y-o-y, but limited sequential growth EBIT revised up 2% for '24...
1% organic sales growth y-o-y Profitability impressed in Q1, ability to offset wage increases We mak...
Ascelia has just concluded a call providing a commercial road-map following the positive SPARKLE res...
EBIT -16% vs cons (SEK 50m vs 60m) and order intake -4% vs cons 80% of order book expected to be del...
Redeye comments on Invisio’s Q1-results which were in line with our expectations and the company saw...
Significant Q1 EBITA beat and comps are getting easier from Q2 Intensified key partnerships and supp...
Redeye will likely keep its forecasts and Base Case largely unchanged following a stable Q1 report m...
Redeye comments on Ultimovacs’ Q1 2024 report, following its INITIUM top-line failure and announced ...
Suominen’s Q1 earnings gained y/y, however the improvement pace was slower than we estimated as EBIT...
Aspo’s Q1 results were burdened by political strikes in Finland especially in the case of ESL, which...
Q1 EBITDA of 13.0m, below ABGSCe USD 15m on higher costs No changes to guidance - Strategic review s...
Redeye saw sales that were just above and results that were below our expectations.
Redeye comments on GiG’s Q1-results which were softer than expected, owing to somewhat lower-than-ex...
Q1 adj. EBITDA 18% below cons, primarily on Platform & Sportsbook Solid start to Q2 with Media sales...
